Teprotumumab-associated aural fullness and ageusia: A case report of persistent complications following thyroid eye disease treatment
Article (October 2024)
The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.
neuroAI
Monograph (August 2024)
Teprotumumab Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA).
Article in Ophthalmic Plastic and Reconstructive Surgery (May 2024)